Kyndryl Accounting Review Triggers Securities Lawsuit, Stock Plummets 52%

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl faces securities lawsuit after SEC discovers accounting irregularities. Stock plunges 52% as CFO and General Counsel resign.

Kyndryl Accounting Review Triggers Securities Lawsuit, Stock Plummets 52%

Kyndryl Holdings, Inc. (NYSE:KD) is facing a class action securities fraud lawsuit following accounting irregularities discovered during an SEC review of the company's internal financial controls. The IT infrastructure services provider delayed the release of its third-quarter 2026 financial statements as a result of the regulatory examination, which identified issues with cash management practices and the company's reporting mechanisms.

The accounting disclosures triggered a significant market reaction on February 9, 2026, when Kyndryl's stock price declined 52% on elevated trading volume. In the wake of the investigation, the company's Chief Financial Officer and General Counsel both departed their positions immediately, signaling the severity of the internal control deficiencies uncovered during the SEC's review.

The lawsuit alleges that Kyndryl misrepresented the state of its accounting practices and the effectiveness of its internal controls to investors. Shareholders who purchased company stock during the relevant period have until April 13, 2026, to join the class action litigation against the technology services firm.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 15

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP